Peter S. Kim
| Peter S. Kim | |
|---|---|
 |
|
| Education | Ph.D., Biochemistry |
| Alma mater | Stanford University Cornell University |
| Employer | Merck & Co., Inc. |
| Known for | Discovering how proteins cause cell membranes to fuse |
| Title | President, Merck Research Laboratories |
| Website | |
| Peter S. Kim Research Papers | |
Peter S. Kim is president[1] of Merck Research Laboratories (MRL).[2] Kim was promoted to this position in January 2003. In this role he oversees all of Merck's drug and vaccine research and development activities.[3]
Kim, a Korean-American, joined the Company in 2001 as executive vice president, Research and Development for MRL.
Kim trained as a structural biologist. He has studied at Stanford University, where he earned his doctorate in biochemistry, and Cornell University, graduating with distinction[4] in chemistry. While at Stanford, he was also a Medical Scientist Training Program Fellow.
Later, Kim worked as a Professor of Biology at Massachusetts Institute of Technology (MIT), and was a Member of the Whitehead Institute and an Investigator at the Howard Hughes Medical Institute.
Kim has a special interest in HIV / AIDS research and designed compounds that stop membrane fusion by the AIDS virus, thereby preventing it from infecting cells. Kim also served as a member of the National Institutes of Health (NIH) Advisory Committee to develop an AIDS vaccine.[4]
His research and work in improving human health has earned Kim numerous awards and other recognition. Some of these honors are noted in the following sections.
Contents |
[edit] Awards
- National Academy of Sciences Award in Molecular Biology
- Eli Lilly Award in Biological Chemistry[5]
- The Hans Neurath Award of the Protein Society[6]
- Samsung Foundation Ho-Am Prize in Basic Science
[edit] Current board memberships and other affiliations
- Member, Council, Institute of Medicine
- Member, Board of Directors, Whitehead Institute for Biomedical Research
- Member, Board of Trustees, Alfred P. Sloan Foundation
- Member, Council, Global HIV Vaccine Enterprise
[edit] Elected memberships
- Member, National Academy of Sciences
- Member, Institute of Medicine
- Member, American Academy of Arts and Sciences[7]
- Fellow, American Association for the Advancement of Science
- Fellow, American Academy of Microbiology
- Fellow, Biophysical Society
- Member, Korean Academy of Science and Technology
[edit] Service
- MIT Corporation, Visiting Committee, Department of Biology, MIT
- External Life Sciences Advisory Council, Cornell University
- Advisory Council, Lewis-Sigler Institute for Integative Genomics, Princeton University
- HARC (HIV Accessory and Regulatory Complexes) Scientific Advisory Board, University of California, San Francisco
